BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, January 2, 2026
Home
»
Authors
» Mark McCarty
Mark McCarty
Articles
ARTICLES
Small hi-tech motors give a grip to new Vanderbilt artificial arm
Aug. 30, 2007
By
Mark McCarty
Hubbard: Lack of funds to blame for flap over FDA outsourcing
Aug. 28, 2007
By
Mark McCarty
No increase in calls, complaints ombudsman’s report indicates
Aug. 27, 2007
By
Mark McCarty
FDA’s most recent warning letter posts include two of a 2006 vintage
Aug. 22, 2007
By
Mark McCarty
Combo product filings down in 2006, but filings more complex
Aug. 21, 2007
By
Mark McCarty
Health Canada poised to roll out user fees for med-tech products
Aug. 17, 2007
By
Mark McCarty
Congress to examine FDA’s handling of Cordis violations
Aug. 16, 2007
By
Mark McCarty
Gebauer, artificial saliva maker, terminates in-house production
Aug. 15, 2007
By
Mark McCarty
Bone density gets cost-effective analytical look in JAMA article
Aug. 13, 2007
By
Mark McCarty
CMS to reexamine non-coverage policy for artificial heart sector
Aug. 9, 2007
By
Mark McCarty
View All Articles by Mark McCarty